Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Doolan

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Developments in Biologicals|November 21, 2001
Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?S L Hoffman, D L Doolan
Chemical Immunology|June 13, 2002
Nucleic acid vaccines against malariaDenise L Doolan, Stephen L Hoffman
Methods in Molecular Medicine|July 20, 2002
DNA vaccinationRichard C Hedstrom, Denise L Doolan
Nature Medicine|November 4, 2000
Malaria vaccines-targeting infected hepatocytesS L Hoffman, D L Doolan
Immunity|October 30, 2010
Malaria vaccine design: immunological considerationsMichael F Good, Denise L Doolan
Parasite Immunology|July 15, 2010
The Australasian contribution to malaria vaccine developmentA M Redmond, D L Doolan
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii modelD L Doolan, S L Hoffman
Memorias Do Instituto Oswaldo Cruz|January 1, 1992
Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variationD L Doolan, M F Good
Human Vaccines & Immunotherapeutics|September 27, 2019
2018 ISV Congress: advances in the 100 years since the world's deadliest pandemicDenise L Doolan, Ted M Ross
Nature Medicine|September 11, 2007
Malaria's journey through the lymph nodeMichael F Good, Denise L Doolan
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Developments in Biologicals|November 21, 2001
Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?S L Hoffman, D L Doolan
Chemical Immunology|June 13, 2002
Nucleic acid vaccines against malariaDenise L Doolan, Stephen L Hoffman
Methods in Molecular Medicine|July 20, 2002
DNA vaccinationRichard C Hedstrom, Denise L Doolan
Nature Medicine|November 4, 2000
Malaria vaccines-targeting infected hepatocytesS L Hoffman, D L Doolan
Immunity|October 30, 2010
Malaria vaccine design: immunological considerationsMichael F Good, Denise L Doolan
Parasite Immunology|July 15, 2010
The Australasian contribution to malaria vaccine developmentA M Redmond, D L Doolan
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii modelD L Doolan, S L Hoffman
Memorias Do Instituto Oswaldo Cruz|January 1, 1992
Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variationD L Doolan, M F Good
Human Vaccines & Immunotherapeutics|September 27, 2019
2018 ISV Congress: advances in the 100 years since the world's deadliest pandemicDenise L Doolan, Ted M Ross
Nature Medicine|September 11, 2007
Malaria's journey through the lymph nodeMichael F Good, Denise L Doolan
Pageof 24